{"id":23290,"date":"2025-03-05T17:02:11","date_gmt":"2025-03-05T18:02:11","guid":{"rendered":"https:\/\/medexperts.pro\/?p=23290"},"modified":"2025-03-05T18:30:12","modified_gmt":"2025-03-05T18:30:12","slug":"florida-seeks-drug-prescription-data-with-names-of-patients-and-doctors","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=23290","title":{"rendered":"Florida Seeks Drug Prescription Data With Names of Patients and Doctors"},"content":{"rendered":"<div><\/div>\n<p id=\"article-summary\" class=\"css-79rysd e1wiw3jv0\">The state\u2019s insurance regulator has demanded detailed information about patients and their medications, raising privacy concerns.<\/p>\n<section class=\"meteredContent css-1r7ky0e\">\n<div class=\"css-s99gbd StoryBodyCompanionColumn\" data-testid=\"companionColumn-0\">\n<div class=\"css-53u6y8\">\n<p class=\"css-at9mc1 evys1bk0\">Florida\u2019s insurance regulator has demanded an unusually intrusive trove of data on millions of prescription drugs filled in the state last year, including the names of patients taking the medications, their dates of birth and doctors they\u2019ve seen.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">The Florida Office of Insurance Regulation in January sought this information from <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2024\/06\/21\/business\/prescription-drug-costs-pbm.html\" title>pharmacy benefit managers<\/a> like UnitedHealth\u2019s Optum Rx and CVS Health\u2019s Caremark, companies that oversee prescription drugs for employers and government programs.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">It remained unclear why the state was ordering the submission of so much data. In a letter to one benefit manager reviewed by The New York Times, the regulator said the state required the data to review whether the benefit managers, known as P.B.M.s, were compliant with a <a class=\"css-yywogo\" href=\"https:\/\/www.facebook.com\/photo.php?fbid=837452764410300&amp;set=pb.100044367518753.-2207520000.&amp;type=3\" title rel=\"noopener noreferrer\" target=\"_blank\">2023 state law<\/a> aimed at lowering drug prices and reining in the managers.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">But the demand is sparking concerns about government overreach and patient privacy.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">\u201cYou don\u2019t need such granular patient information for purposes of oversight,\u201d said Sharona Hoffman, a health law and privacy expert at Case Western Reserve University. She added: \u201cYou have to worry: Is the government actually trying to get information about reproductive care or transgender care or mental health care?\u201d<\/p>\n<\/div>\n<\/div>\n<div data-testid=\"Dropzone-1\"><\/div>\n<div class=\"css-s99gbd StoryBodyCompanionColumn\" data-testid=\"companionColumn-1\">\n<div class=\"css-53u6y8\">\n<p class=\"css-at9mc1 evys1bk0\">Florida\u2019s six-week abortion ban, enacted by Gov. Ron DeSantis, a Republican, and the state\u2019s Republican-dominated legislature, requires that doctors who prescribe abortion pills dispense them in person, not through the mail. Another Florida law banned transgender transition care for minors and made it harder for adults to seek such care. Last year, a judge <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2024\/06\/11\/us\/florida-transgender-law.html\" title>struck down<\/a> key parts of that law, though it is still <a class=\"css-yywogo\" href=\"https:\/\/www.tallahassee.com\/story\/news\/politics\/2024\/08\/27\/florida-transgender-gender-affirming-ban-restrictions-court-lawsuit\/74962845007\/\" title rel=\"noopener noreferrer\" target=\"_blank\">being enforced<\/a> while the legal fight makes its way through the courts.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">The data requested by the state could, in theory, be used to determine whether physicians are complying with those laws.<\/p>\n<div class=\"css-1336jj\">\n<div class=\"css-121kum4\">\n<div class=\"css-171quhb\"><\/div>\n<div class=\"css-asuuk5\">\n<div class=\"css-7axq9l\" data-testid=\"optimistic-truncator-noscript\">\n<div data-testid=\"optimistic-truncator-noscript-message\" class=\"css-6yo1no\">\n<p class=\"css-3kpklk\">We are having trouble retrieving the article content.<\/p>\n<p class=\"css-3kpklk\">Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n<div class=\"css-1dv1kvn\" id=\"optimistic-truncator-a11y\">\n<hr \/>\n<p>Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0<a href=\"https:\/\/myaccount.nytimes.com\/auth\/login?response_type=cookie&amp;client_id=vi&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F03%2F05%2Fhealth%2Fflorida-prescriptions-patient-privacy-data.html&amp;asset=opttrunc\">log into<\/a>\u00a0your Times account, or\u00a0<a href=\"https:\/\/www.nytimes.com\/subscription?campaignId=89WYR&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F03%2F05%2Fhealth%2Fflorida-prescriptions-patient-privacy-data.html\">subscribe<\/a>\u00a0for all of The Times.<\/p>\n<hr \/>\n<\/div>\n<div class=\"css-1g71tqy\">\n<div data-testid=\"optimistic-truncator-message\" class=\"css-6yo1no\">\n<p class=\"css-3kpklk\">Thank you for your patience while we verify access.<\/p>\n<p class=\"css-3kpklk\">Already a subscriber?\u00a0<a data-testid=\"log-in-link\" class=\"css-z5ryv4\" href=\"https:\/\/myaccount.nytimes.com\/auth\/login?response_type=cookie&amp;client_id=vi&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F03%2F05%2Fhealth%2Fflorida-prescriptions-patient-privacy-data.html&amp;asset=opttrunc\">Log in<\/a>.<\/p>\n<p class=\"css-3kpklk\">Want all of The Times?\u00a0<a data-testid=\"subscribe-link\" class=\"css-z5ryv4\" href=\"https:\/\/www.nytimes.com\/subscription?campaignId=89WYR&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F03%2F05%2Fhealth%2Fflorida-prescriptions-patient-privacy-data.html\">Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>The state\u2019s insurance regulator has demanded detailed information about patients and their medications, raising privacy concerns.Florida\u2019s insurance regulator has demanded an unusually intrusive trove of data on millions of prescription drugs filled in the state last year, including the names of patients taking the medications, their dates of birth and doctors they\u2019ve seen.The Florida Office of Insurance Regulation in January sought this information from pharmacy benefit managers like UnitedHealth\u2019s Optum Rx and CVS Health\u2019s Caremark, companies that oversee prescription drugs for employers and government programs.It remained unclear why the state was ordering the submission of so much data. In a letter to one benefit manager reviewed by The New York Times, the regulator said the state required the data to review whether the benefit managers, known as P.B.M.s, were compliant with a 2023 state law aimed at lowering drug prices and reining in the managers.But the demand is sparking concerns about government overreach and patient privacy.\u201cYou don\u2019t need such granular patient information for purposes of oversight,\u201d said Sharona Hoffman, a health law and privacy expert at Case Western Reserve University. She added: \u201cYou have to worry: Is the government actually trying to get information about reproductive care or transgender care or mental health care?\u201dFlorida\u2019s six-week abortion ban, enacted by Gov. Ron DeSantis, a Republican, and the state\u2019s Republican-dominated legislature, requires that doctors who prescribe abortion pills dispense them in person, not through the mail. Another Florida law banned transgender transition care for minors and made it harder for adults to seek such care. Last year, a judge struck down key parts of that law, though it is still being enforced while the legal fight makes its way through the courts.The data requested by the state could, in theory, be used to determine whether physicians are complying with those laws.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":23292,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[],"class_list":["post-23290","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/23290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23290"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/23290\/revisions"}],"predecessor-version":[{"id":23293,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/23290\/revisions\/23293"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/23292"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}